BeiGene Corp - ONC Projected Future Earnings

Public company logo of BeiGene Ltd (ONC)

BeiGene Ltd (ONC) outsources its anti-tumor drug testing to external CRO partners in strict compliance with regulations. This chart reflects profits at 1.11, while the business resists expansion by global pharmaceutical behemoths. A technological edge is driven by the success of Brukinsa and accessible research in China, which strengthens the firm's market position.

ONC - BeiGene Ltd Projected Future Earnings over the range 02/27/2025 - 11/17/2026

Metric breakdowns and analytics for BeiGene Corp (ONC)

- stock quotes and analyst forecast:
Summary company analysis:BeiGene Oncology, ONC
Finished products of BeiGene Ltd.

Defensive assets are selected based on their ability to generate stable cash flow, which for BeiGene Ltd (ONC) is ensured by unique patents and large-scale investments in oncology research. The consensus net income per share forecast, reflected in the forward earnings trend, allows for an assessment of the business's fundamental value while accounting for regulatory risks in China and the US and filtering out short-term market noise.

Competitors of BeiGene Ltd

Expected Profit Halozyme|RVMD: Expected Net Income|Future Profit AAPG (Ascentage)|CGON (CG Oncology Corp) - Expected Net Income|Projected Future Earnings URGN (urogen.com)|BCAX - Future Profit|PSNL: Future Profit|ERAS - Projected Future Earnings|Delcath (DCTH) - Expected Profit|YmAbs - Expected Net Income|AURA (Aura Biosciences Inc) - Projected Future Earnings|Expected Net Profit Candel Therapeutics CADL|Projected Future Earnings ARAY|SLS - Expected Net Profit|Projected Future Earnings ACTU (Actuate Therapeutics Inc)|Company Profit Forecast Citius Oncology, Inc. (CTOR)|TuHURA Biosciences - Projected Future Earnings|Expected Net Profit Protara Therapeutics, Inc.|FATE: Projected Future Earnings|WHWK - Company Profit Forecast|Expected Profit TScan Therapeutics, Inc.|Champions Oncology - Forward Earnings|Projected Future Earnings XBIT|Company Profit Forecast CEL-SCI Corp|Expected Profit OS Therapies OSTX|Expected Net Income RADX|artivabio.com - Projected Future Earnings|Expected Net Income ANL (Adlai Nortye Ltd)|VERU (verupharma.com) - Future Profit|TPST: Future Net Profit|XLO (Xilio) - Projected Future Earnings|renovarobio.com (RENB) - Company Profit Forecast|Expected Profit Mural Oncology (MURA)|KAPA (Kairos Pharma Limited) - Expected Net Income|Projected Future Earnings OKUR (OnKure Therapeutics, Inc.)|Expected Net Income GDTC|Curis Inc. - Projected Future Earnings|APLM (apollomicsinc.com) - Net Profit Forecast|THAR: Projected Future Earnings|Expected Net Profit Advanced Biomed Inc. (ADVB)|Expected Profit Genprex, Inc|Projected Future Earnings calidibio.com|Expected Profit Sunshine Biopharma (SBFM)|Xenetic Biosciences, Inc. - Net Profit Forecast|Projected Future Earnings SLRX (salariuspharma.com)|Purple Biotech - Expected Profit|AONC: Future Profit|BGNE - Projected Future Earnings|CKPT (checkpointtx.com) - Future Profit|Expected Net Profit elevationoncology.com (ELEV)|Future Profit ICAD|ikenaoncology.com (IKNA) - Company Profit Forecast|Expected Profit Notable Labs, Ltd. (NTBL)|Expected Profit VIRX (Viracta Therapeutics, Inc.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit